Related Experiment Videos
Minor H antigens: genes and peptides
1MRC Clinical Sciences Centre, Imperial College Faculty of Medicine, Hammersmith Hospital, London, UK. elizabeth.simpson@csc.mrc.ac.uk
Transplant Immunology
|September 10, 2002
Summary
Minor histocompatibility (H) antigens are key targets in bone marrow transplantation. Identifying their molecular details helps predict and manage transplant outcomes, improving patient therapy.
Area of Science:
- Immunology
- Transplantation Biology
- Molecular Genetics
Background:
- Non-MHC histocompatibility (H) antigens are crucial in bone marrow transplantation (BMT).
- These antigens are significant targets for T cell responses post-transplant.
- Their molecular identity and clinical relevance are areas of active research.
Purpose of the Study:
- To review the evidence for non-MHC H antigens.
- To discuss their role in BMT and T cell responses.
- To present the current molecular understanding of minor H antigens.
Main Methods:
- Review of existing scientific literature and clinical data.
- Molecular identification of peptide epitopes, MHC restriction molecules, and encoding genes for human and murine minor H antigens.
- Enumeration of T cell responses using tetramer and ELISPOT assays.
Main Results:
- Detailed listing of identified peptide epitopes, MHC restriction, and genes for human and murine minor H antigens.
- Methodologies established for quantifying T cell responses to these antigens.
- Potential for using minor H peptides to modulate immune responses.
Conclusions:
- Molecular identification of minor H antigens facilitates analysis of graft-versus-host (GVH) and graft-versus-leukemia (GVL) reactions.
- Understanding immunodominance is critical for predicting transplant outcomes and tailoring therapy.
- Further research is needed to elucidate factors controlling T cell responses to minor H antigens.